Literature DB >> 8239569

Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.

B J Snow1, T G Nygaard, H Takahashi, D B Calne.   

Abstract

There are two major syndromes presenting in the early decades of life with dystonia and parkinsonism: dopa-responsive dystonia (DRD) and early-onset idiopathic parkinsonism (EOIP). DRD presents predominantly in childhood with prominent dystonia and lesser degrees of parkinsonism. EOIP presents before age 40 with parkinsonism (often with associated dystonia). Both disorders are exquisitely sensitive to levodopa, although the long-term prognosis in each appears to be different. Some have suggested, however, that DRD is a form of EOIP. We performed positron emission tomography with 6-fluoro-dopa in 10 patients with DRD and 18 patients with EOIP to study the integrity of their nigrostriatal dopaminergic systems. In DRD, we found normal striatal FD uptake. In contrast, patients with EOIP had reduced striatal FD uptake. We conclude that the patho-physiologies of DRD and EOIP are distinct. Although both disorders presumably represent a deficiency of striatal dopamine, the results suggest that in DRD dopa uptake, decarboxylation, and storage mechanisms are intact. This may explain the sustained response of DRD to low doses of levodopa. 6-Fluoro-dopa positron emission tomography distinguishes DRD from EOIP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239569     DOI: 10.1002/ana.410340518

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

Review 1.  Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review.

Authors:  Ajith Cherian; Naveen Kumar Paramasivan; K P Divya
Journal:  Acta Neurol Belg       Date:  2021-01-16       Impact factor: 2.396

2.  Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Authors:  Joanne Terbeek; Sylvia Hermans; Koen Van Laere; Wim Vandenberghe
Journal:  Brain       Date:  2014-11-28       Impact factor: 13.501

Review 3.  Imaging insights into basal ganglia function, Parkinson's disease, and dystonia.

Authors:  A Jon Stoessl; Stephane Lehericy; Antonio P Strafella
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

4.  The usefulness of functional imaging in movement disorders: an illustrative case.

Authors:  K P Bhatia; N Turjanski; D J Brooks; C D Marsden; D Thrush
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

Review 5.  Imaging the head: functional imaging.

Authors:  G V Sawle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

6.  A new knock-in mouse model of l-DOPA-responsive dystonia.

Authors:  Samuel J Rose; Xin Y Yu; Ann K Heinzer; Porter Harrast; Xueliang Fan; Robert S Raike; Valerie B Thompson; Jean-Francois Pare; David Weinshenker; Yoland Smith; Hyder A Jinnah; Ellen J Hess
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

Review 7.  Neuroimaging findings in children with paediatric neurotransmitter diseases.

Authors:  Wang-Tso Lee; Wen-Chin Weng; Shinn-Forng Peng; Kai-Yuan Tzen
Journal:  J Inherit Metab Dis       Date:  2009-05-20       Impact factor: 4.982

8.  GCH1 Deficiency Activates Brain Innate Immune Response and Impairs Tyrosine Hydroxylase Homeostasis.

Authors:  Hannah Larbalestier; Marcus Keatinge; Lisa Watson; Emma White; Siri Gowda; Wenbin Wei; Katjusa Koler; Svetlana A Semenova; Adam M Elkin; Neal Rimmer; Sean T Sweeney; Julie Mazzolini; Dirk Sieger; Winston Hide; Jonathan McDearmid; Pertti Panula; Ryan B MacDonald; Oliver Bandmann
Journal:  J Neurosci       Date:  2021-12-07       Impact factor: 6.709

Review 9.  Clinical spectrum of dopa-responsive dystonia and related disorders.

Authors:  Woong-Woo Lee; Beom Seok Jeon
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

10.  Reply: Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Authors:  Niccolo E Mencacci; Alan M Pittman; Ioannis U Isaias; John Hardy; Stephan Klebe; Kailash P Bhatia; Nicholas W Wood
Journal:  Brain       Date:  2014-11-14       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.